Drugs / TRICOM-CEA(6D)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00027534 | Jan 2002 → Oct 2007 | breast cancer, colorectal cancer, gallbladder cancer, gastric cancer +5 | Michael Morse, MD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TRICOM-CEA(6D) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00027534 ↗ |
| Modality | Vaccine | “recombinant fowlpox-CEA-TRICOM vaccine” NCT00027534 ↗ |